Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
47
Employees47
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
47
Employees47

LGND Key Statistics

Market cap
4.49B
Market cap4.49B
Price-Earnings ratio
37.89
Price-Earnings ratio37.89
Dividend yield
Dividend yield
Average volume
258.77K
Average volume258.77K
High today
$230.43
High today$230.43
Low today
$221.77
Low today$221.77
Open price
$230.43
Open price$230.43
Volume
305.14K
Volume305.14K
52 Week high
$234.76
52 Week high$234.76
52 Week low
$98.89
52 Week low$98.89

Stock Snapshot

Ligand Pharmaceuticals(LGND) stock is priced at $225.09, giving the company a market capitalization of 4.49B. It carries a P/E multiple of 37.89.

As of 2026-04-15, Ligand Pharmaceuticals(LGND) stock has fluctuated between $221.77 and $230.43. The current price stands at $225.09, placing the stock +1.5% above today's low and -2.3% off the high.

The Ligand Pharmaceuticals(LGND)'s current trading volume is 305.14K, compared to an average daily volume of 258.77K.

During the past year, Ligand Pharmaceuticals(LGND) stock moved between $98.89 at its lowest and $234.76 at its peak.

During the past year, Ligand Pharmaceuticals(LGND) stock moved between $98.89 at its lowest and $234.76 at its peak.

LGND News

Simply Wall St 5h
Ligand Pharmaceuticals Is Up 13.3% After Securing 9% Royalty on Newly Approved FILSPARI

Ligand Pharmaceuticals recently reported that its partner Travere Therapeutics received full FDA approval for FILSPARI (sparsentan) to reduce proteinuria in adu...

Ligand Pharmaceuticals Is Up 13.3% After Securing 9% Royalty on Newly Approved FILSPARI
TipRanks 1d
This Is Why Travere Therapeutics Stock Surged Today

Travere Therapeutics (TVTX) stock surged on Tuesday after the biopharmaceutical company received full approval for FILSPARI from the U.S. Food and Drug Administ...

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.